Transcriptional Regulation of Neuropeptide Receptors Decodes Complexity of Peptidergic Modulation of Behavior and Physiology.

The modulation of complex behaviors in response to environmental and physiological contexts is a fundamental aspect of animal biology, with neuropeptides (NPs) playing a crucial role in this process. This study investigates the transcriptional regulation of neuropeptide receptors (NPRs) as a mechanism for context-dependent neuropeptidergic modulation of physiology and behavior. We hypothesize that the transcriptional control of NPR genes, rather than the NPs themselves, is a critical determinant in the context-dependent modulation of behavior and physiology. Using a multi-faceted approach, including comparative genomics, transcription factor network analysis, and empirical validation in model organisms such as Drosophila melanogaster, we reveal a complex regulatory landscape where NPR expression is tightly controlled. Our findings demonstrate that NPR genes exhibit a higher number of enhancers, CTCF-binding sites, and open chromatin regions compared to NP genes, suggesting a greater susceptibility to transcriptional modulation. This regulatory architecture allows for precise control over neuropeptidergic signaling, enabling dynamic and context-specific behavioral and physiological responses. Our results highlight the importance of NPR-expressing cells by transcriptional regulation in mediating the effects of NPs on behavior and physiology. We show that this regulation is conserved across species, indicating an evolutionarily significant mechanism for fine-tuning neuropeptidergic signaling. Furthermore, our study provides insights into the distinct regulatory mechanisms underlying the multifunctionality of NPs and their receptors, offering a novel perspective on the transcriptional control of complex behaviors. In conclusion, this study advances our understanding of neuropeptidergic signaling by focusing on the transcriptional regulation of NPRs. Our findings have broad implications for the development of therapeutic strategies targeting neuropeptidergic systems in various neurological and behavioral disorders.